Prothrombotic properties. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Blood Platelets Endothelium, Vascular Cell-Derived Microparticles Portal Vein Endothelial Cells Cells, Cultured Umbilical Veins Monocytes Neutrophils

Organisms4

Sapotaceae Mice, Knockout Mice, Inbred C57BL Mice, Transgenic

Diseases38

Thrombosis Thrombophilia Protein S Deficiency Blood Coagulation Disorders Protein C Deficiency Venous Thrombosis Activated Protein C Resistance Thromboembolism Blood Coagulation Disorders, Inherited Antiphospholipid Syndrome Sinus Thrombosis, Intracranial Intracranial Thrombosis Carotid Artery Thrombosis Hypoprothrombinemias Antithrombin III Deficiency Factor V Deficiency Budd-Chiari Syndrome Atrial Fibrillation Thrombocytopenia Stroke Inflammation Hyperhomocysteinemia Brain Ischemia Coronary Thrombosis Pulmonary Embolism Myocardial Infarction Hypercholesterolemia Atherosclerosis Genetic Predisposition to Disease Disease Models, Animal Cardiovascular Diseases Lupus Erythematosus, Systemic Coronary Artery Disease Arteriosclerosis Metabolic Syndrome X Hypertension Recurrence Chronic Disease

Chemicals and Drugs46

Prothrombin Factor V Thromboplastin Fibrin Fibrinogen Degradation Products Estrogens, Esterified (USP)Antithrombin III Lupus Coagulation Inhibitor von Willebrand Factor Antibodies, Anticardiolipin Thrombomodulin Plasminogen Activator Inhibitor 1 Fibrinogen Protein C P-Selectin Antibodies, Antiphospholipid Protein S Methylenetetrahydrofolate Reductase (NADPH2)Anticoagulants Thrombin Blood Coagulation Factors Oxidoreductases Acting on CH-NH Group Donors Mesterolone Platelet Factor 4 beta-Thromboglobulin beta 2-Glycoprotein I Factor VII Antithrombins Aspirin Biological Markers Heparin CD40 Ligand Fibrin Fibrinolytic Agents Tissue Plasminogen Activator Factor VIIa Homocysteine Platelet Aggregation Inhibitors Factor VIII Lipoprotein(a)C-Reactive Protein Warfarin Peptide Fragments Peptide Hydrolases Adenosine Diphosphate Lipoproteins RNA, Messenger

Analytical, Diagnostic and Therapeutic Techniques and Equipment20

Blood Coagulation Tests Risk Factors Prothrombin Time Partial Thromboplastin Time Case-Control Studies Platelet Count Platelet Function Tests Prospective Studies Disease Models, Animal Enzyme-Linked Immunosorbent Assay Risk Assessment Follow-Up Studies Cohort Studies Prevalence Odds Ratio Treatment Outcome Risk Retrospective Studies Cross-Sectional Studies Flow Cytometry

Phenomena and Processes25

Platelet Activation Blood Coagulation Hemostasis Fibrinolysis Platelet Aggregation Platelet Adhesiveness Prothrombin Time Partial Thromboplastin Time Homozygote Platelet Count Heterozygote Point Mutation Polymorphism, Genetic Genetic Predisposition to Disease Time Factors Mutation Phenotype Genotype Dose-Response Relationship, Drug Odds Ratio Risk Up-Regulation Gene Expression Regulation Pregnancy Signal Transduction

Information Science1

Named Groups1

Infant, Newborn

Health Care12

Risk Factors Case-Control Studies Prospective Studies Risk Assessment Follow-Up Studies Cohort Studies Prevalence Odds Ratio Treatment Outcome Risk Retrospective Studies Cross-Sectional Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Named Groups Health Care

Thrombosis Thrombophilia Prothrombin Factor V Platelet Activation Blood Coagulation Thromboplastin Protein S Deficiency Blood Coagulation Disorders Protein C Deficiency Venous Thrombosis Hemostasis Fibrin Fibrinogen Degradation Products Estrogens, Esterified (USP)Activated Protein C Resistance Antithrombin III Blood Platelets Thromboembolism Lupus Coagulation Inhibitor von Willebrand Factor Antibodies, Anticardiolipin Thrombomodulin Plasminogen Activator Inhibitor 1 Fibrinogen Protein C P-Selectin Fibrinolysis Antibodies, Antiphospholipid Protein S Blood Coagulation Disorders, Inherited Antiphospholipid Syndrome Methylenetetrahydrofolate Reductase (NADPH2)Sinus Thrombosis, Intracranial Anticoagulants Thrombin Blood Coagulation Factors Sapotaceae Intracranial Thrombosis Blood Coagulation Tests Risk Factors Carotid Artery Thrombosis Hypoprothrombinemias Oxidoreductases Acting on CH-NH Group Donors Platelet Aggregation Mesterolone Platelet Factor 4 Antithrombin III Deficiency beta-Thromboglobulin beta 2-Glycoprotein I Factor V Deficiency Factor VII Antithrombins Aspirin Platelet Adhesiveness Biological Markers Heparin Budd-Chiari Syndrome Prothrombin Time CD40 Ligand Fibrin Endothelium, Vascular Fibrinolytic Agents Partial Thromboplastin Time Tissue Plasminogen Activator Case-Control Studies Cell-Derived Microparticles Homozygote Factor VIIa Homocysteine Platelet Aggregation Inhibitors Platelet Count Platelet Function Tests Atrial Fibrillation Thrombocytopenia Heterozygote Point Mutation Stroke Factor VIII Inflammation Hyperhomocysteinemia Brain Ischemia Lipoprotein(a)Portal Vein Coronary Thrombosis C-Reactive Protein Pulmonary Embolism Endothelial Cells Warfarin Prospective Studies Polymorphism, Genetic Mice, Knockout Myocardial Infarction Hypercholesterolemia Atherosclerosis Genetic Predisposition to Disease Peptide Fragments Disease Models, Animal Peptide Hydrolases Cardiovascular Diseases Lupus Erythematosus, Systemic

No FAQ available that match "prothrombotic properties"